Levels of Circulating T Cells Expressing VLA-1 Collagen Receptors
NCT ID: NCT00708838
Last Updated: 2008-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
151 participants
OBSERVATIONAL
2002-01-31
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autoimmunity and Coronary Artery Disease - Ancillary to CARDIA
NCT00106483
Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients
NCT00562653
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
NCT03575910
ST Elevation in Acute Chest Pain; Could Measurement of Lipoprotein-associated Phospholipase A2 (Lp-PLA2) be Helpful to the Clinician?
NCT01041339
The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
NCT02013037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No interventions assigned to this group
2
No interventions assigned to this group
3
No interventions assigned to this group
4
No interventions assigned to this group
5
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical diagnosis of ACSl for group 2
* clinical diagnosis of Chronic Heart Disease for groups 3 and 4
* Chest pain but normal heart scan for group 5
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheba Medical Center, Heart Institute
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-02-2707-AA-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.